Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06650833 in COVID-19 Pneumonia
NCT04933799Phase 2Unknown
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
A Phase 2 trial of zimlovisertib in COVID-19 pneumonia. Status: unknown.
02
Drugs
zimlovisertib
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04933799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04933799.